Evidence map›Paper›PMID 41912845›Full record

ArticleDoklady. Biochemistry and biophysics2026

Trans-Splicing Enhances Processivity of RNA Polymerase II and Suppresses Polyadenylation Signals.

Iu V Soldatova, O Beginyazova, L S Melnikova, A K Golovnin, O G Maksimenko, P G Georgiev, M V Tikhonov

Abstract read
PubMed Publisher
In one paragraph

Article in Doklady. Biochemistry and biophysics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Iu V SoldatovaInstitute of Gene Biology, Russian Academy of Sciences, Moscow, Russia.
O BeginyazovaInstitute of Gene Biology, Russian Academy of Sciences, Moscow, Russia.
L S MelnikovaInstitute of Gene Biology, Russian Academy of Sciences, Moscow, Russia.
A K GolovninInstitute of Gene Biology, Russian Academy of Sciences, Moscow, Russia.
O G MaksimenkoInstitute of Gene Biology, Russian Academy of Sciences, Moscow, Russia.
P G GeorgievInstitute of Gene Biology, Russian Academy of Sciences, Moscow, Russia.
M V TikhonovInstitute of Gene Biology, Russian Academy of Sciences, Moscow, Russia. me@mtih.me.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Trans-splicing, the process where exons from two different pre-mRNA molecules are joined, is an efficient mechanism for generating diverse isoforms encoded by a single locus. This process has been most thoroughly studied in the mod(mdg4) locus of Drosophila. This locus comprises one gene encoding the constant N-terminal part of the Mod(mdg4) protein and five genes that encode over thirty 3'-exons clustered together, determining the diversity of C-terminal domains. In this study, transgenic lines were obtained where a strong polyadenylation signal from the SV40 virus was inserted into two 3'-exon clusters with the aim of halting transcription and, consequently, reducing the frequency of trans-splicing between the constant exons of the mod(mdg4) gene and the 3'-exons of the modified clusters. Unexpectedly, it was found that SV40 polyadenylation signals had no effect on either the transcription level of the clusters or the efficiency of trans-splicing. The results indicate the ability of RNA polymerase II, transcribing the 3'-exons of the mod(mdg4) locus, to overcome even strong polyadenylation signals from SV40.

Indexed as

Drosophila ProteinsPolyadenylationRNA Polymerase IITrans-SplicingAnimalsDrosophila melanogasterExonsDrosophila ProteinsRNA Polymerase IIalternative splicingDrosophila melanogastermod(mdg4)polyadenylation signaltrans-splicing

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.